左主支疾病醫(yī)學(xué)證據(jù)基礎(chǔ)和現(xiàn)實(shí)世界（英文）課件_第1頁(yè)
左主支疾病醫(yī)學(xué)證據(jù)基礎(chǔ)和現(xiàn)實(shí)世界（英文）課件_第2頁(yè)
左主支疾病醫(yī)學(xué)證據(jù)基礎(chǔ)和現(xiàn)實(shí)世界（英文）課件_第3頁(yè)
左主支疾病醫(yī)學(xué)證據(jù)基礎(chǔ)和現(xiàn)實(shí)世界（英文）課件_第4頁(yè)
左主支疾病醫(yī)學(xué)證據(jù)基礎(chǔ)和現(xiàn)實(shí)世界（英文）課件_第5頁(yè)
已閱讀5頁(yè)，還剩25頁(yè)未讀， 繼續(xù)免費(fèi)閱讀

下載本文檔

版權(quán)說(shuō)明：本文檔由用戶提供并上傳，收益歸屬內(nèi)容提供方，若內(nèi)容存在侵權(quán)，請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)

文檔簡(jiǎn)介

1、Lu Shuzheng M.D. FAPSIC.Beijing Anzhen HospitalCapital Medical UniversityLeft Main Disease: Evidence-base Medicine & Realistic World左主支疾病醫(yī)學(xué)證據(jù)基礎(chǔ)和現(xiàn)實(shí)世界（英文）1Anatomy importance of LMoCompromises flow to approximately 75% of the left ventricle;oAcute occlusion of ULMCA will cause MI ,cardiac shock or

2、acute heart failure, cardiac arrest(50%70%).左主支疾病醫(yī)學(xué)證據(jù)基礎(chǔ)和現(xiàn)實(shí)世界（英文）2Anatomy features of LMCA DiseaseoMost elastic tissue;oHigher elastic radial force.左主支疾病醫(yī)學(xué)證據(jù)基礎(chǔ)和現(xiàn)實(shí)世界（英文）3Classification based on location of lesionsOstium Shaft/Body Distal左主支疾病醫(yī)學(xué)證據(jù)基礎(chǔ)和現(xiàn)實(shí)世界（英文）4左主支疾病醫(yī)學(xué)證據(jù)基礎(chǔ)和現(xiàn)實(shí)世界（英文）5Clinical Results of DES

3、 for ULMCA左主支疾病醫(yī)學(xué)證據(jù)基礎(chǔ)和現(xiàn)實(shí)世界（英文）6DES for the ULMCAPark et al.Chieffo et al.Valgimgli et al.Lee et al.Price et al.Migliorini et al.Erglis et al.Patients, n1028595505010153Distal lesion location(%)71816560948781Cardiac mortality,612 months(%)03.51142112Angiographic follow up(%)84.3NRNR429896100Angiograp

4、hic restenosis (%)7 *19 NRNR44 16 *6 *TLR or TVR(%)2 18.8 6.3 13 38 14 2 *Follow-up angiography at 6 moths. Fellow-up angiography at 4 to 8 months. Fellow-up angiography at 3 and 9 months. Target lessin revascularization. Target vessel revascularization (TVR). Date from Baim et al.DES drug eluting s

5、tent; NR not reported. 左主支疾病醫(yī)學(xué)證據(jù)基礎(chǔ)和現(xiàn)實(shí)世界（英文）7(3.7-7.7)Recent Meta-Analysis of 1,278 Patients Undergoing UPLM DES From 15 RegistriesDate from Biondi-Zoccai et alDES for the ULMCA(3.4-7.7)左主支疾病醫(yī)學(xué)證據(jù)基礎(chǔ)和現(xiàn)實(shí)世界（英文）8Recent Meta-Analysis of 1,278 Patients Undergoing UPLM DES From 15 RegistriesDate from Biondi-

6、Zoccai et alDES for the ULMCA(3.7-9.2)左主支疾病醫(yī)學(xué)證據(jù)基礎(chǔ)和現(xiàn)實(shí)世界（英文）9PCI vs. CABG Bologna Registry左主支疾病醫(yī)學(xué)證據(jù)基礎(chǔ)和現(xiàn)實(shí)世界（英文）10PCI vs. CABG Milan experience左主支疾病醫(yī)學(xué)證據(jù)基礎(chǔ)和現(xiàn)實(shí)世界（英文）11PCI vs. CABG Cedars Sinai Registry左主支疾病醫(yī)學(xué)證據(jù)基礎(chǔ)和現(xiàn)實(shí)世界（英文）12LE MANS Study designNumber of patients screened with ULMCA Disease:347Patients elig

7、ible for study:122Patients noneligible for study included in LE MANS Registry:225Randomized patients:105Nonrandomized patients:17PCI102CABG123PCI52CABG53PCI9CABG8All patients treated according to randomization (no crossover)First RCT study of ULMCA左主支疾病醫(yī)學(xué)證據(jù)基礎(chǔ)和現(xiàn)實(shí)世界（英文）13LE MANS Study baselineVariable

8、sPCI(n=52)CABG(n=53)P ValueAge (yrs)60.610.561.38.40.69Male (%)60730.13CCS class3.11.02.81.00.17LVEF (%)21170.58Distal LM disease (%)56600.63No. of diseased vessels1.730.932.08 0.830.33DES/arterial graft to LAD (%) 3581-Complete revascularization (%)79890.17Hospitalization (days)6.8 3.712.04 9.60.00

9、07左主支疾病醫(yī)學(xué)證據(jù)基礎(chǔ)和現(xiàn)實(shí)世界（英文）14LE MANS Study LVEF at baseline and after 12 monthsp=0.22p=0.04p=0.01p=0.85左主支疾病醫(yī)學(xué)證據(jù)基礎(chǔ)和現(xiàn)實(shí)世界（英文）15LE MANS Study CCS function class at baseline and follow-upp=0.22p=0.01p=0.10p=0.01p=0.11左主支疾病醫(yī)學(xué)證據(jù)基礎(chǔ)和現(xiàn)實(shí)世界（英文）16LE MANS Study treadmill stress tests at baseline and follow-upp=0.03p=

10、0.31p=0.97p=0.53左主支疾病醫(yī)學(xué)證據(jù)基礎(chǔ)和現(xiàn)實(shí)世界（英文）17LE MANS StudyPCICABGSurvival after PCI and CABGMACCE-Free Survival after PCI and CABGPCICABG左主支疾病醫(yī)學(xué)證據(jù)基礎(chǔ)和現(xiàn)實(shí)世界（英文）18More RCT Trial Needed左主支疾病醫(yī)學(xué)證據(jù)基礎(chǔ)和現(xiàn)實(shí)世界（英文）19ULMCA in Realistic World左主支疾病醫(yī)學(xué)證據(jù)基礎(chǔ)和現(xiàn)實(shí)世界（英文）20Left Main StrategiesOstium LesionsShaft LesionsBifurcation

11、Lesions左主支疾病醫(yī)學(xué)證據(jù)基礎(chǔ)和現(xiàn)實(shí)世界（英文）21What do you think about this patientoMale, 73y;oExertional Chest Pain 3m, Aggravated 10d;oDiag: CAD UAP Braunwald B;oOther RF: HT, Smoking;oEcho: EF 68%, LVEDD 50mm;oTo Cath Lab.左主支疾病醫(yī)學(xué)證據(jù)基礎(chǔ)和現(xiàn)實(shí)世界（英文）224 Bifurcation Lesions oWhich one is the first;oTechnique of each lesion

12、; oV/T/Kissing stent for LM;oHow to do the final kissing.CrossoverT StentT StentCrush左主支疾病醫(yī)學(xué)證據(jù)基礎(chǔ)和現(xiàn)實(shí)世界（英文）23GC: 7F JL4; GW: Stablizer Supersoft, Runthrough, Rinato, ATW; BC: Sprinter 2.5*15mm, Sprinter 1.5*15mm;SC: SES 3.0*24mm, SES 2.5*33mm左主支疾病醫(yī)學(xué)證據(jù)基礎(chǔ)和現(xiàn)實(shí)世界（英文）24SC: SES 2.5*18mm, SES 3.5*18mm左主支疾病醫(yī)學(xué)證

13、據(jù)基礎(chǔ)和現(xiàn)實(shí)世界（英文）25GW: Pilot50; BC: Sequent 3.0*10mm SC: SES 4.0*15mm左主支疾病醫(yī)學(xué)證據(jù)基礎(chǔ)和現(xiàn)實(shí)世界（英文）26Final Result左主支疾病醫(yī)學(xué)證據(jù)基礎(chǔ)和現(xiàn)實(shí)世界（英文）27CABG vs. DES our experiencesLesions DistributionFrom 2004 to 2006, 393 pts with LM lesions, FU 4y, Registry Study255 pts in CABG Group & 138 pts in DES GroupDifferent Techniques of Bifurcation Lesions左主支疾病醫(yī)學(xué)證據(jù)基礎(chǔ)和現(xiàn)實(shí)世界（英文）28CABG vs. DES our experiencesp0.0

溫馨提示

  • 1. 本站所有資源如無(wú)特殊說(shuō)明，都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
  • 2. 本站的文檔不包含任何第三方提供的附件圖紙等，如果需要附件，請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
  • 3. 本站RAR壓縮包中若帶圖紙，網(wǎng)頁(yè)內(nèi)容里面會(huì)有圖紙預(yù)覽，若沒有圖紙預(yù)覽就沒有圖紙。
  • 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
  • 5. 人人文庫(kù)網(wǎng)僅提供信息存儲(chǔ)空間，僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理，對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯，并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
  • 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容，請(qǐng)與我們聯(lián)系，我們立即糾正。
  • 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。

最新文檔

評(píng)論

0/150

提交評(píng)論